Cargando…

Editorial: Interplay between epigenetic modifiers and transcription factors in driving cancer progression

Detalles Bibliográficos
Autores principales:	Yang, Yongyong, Di Ruscio, Annalisa, Inoue, Satoshi, Wang, Guocan, Gao, Shuai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315910/ https://www.ncbi.nlm.nih.gov/pubmed/37404748 http://dx.doi.org/10.3389/fonc.2023.1211537

Ejemplares similares

Editorial: The Role of Epigenetic Modifications in Cancer Progression
por: Fujimura, Atsushi, et al.
Publicado: (2021)

Metabolic Dysregulations and Epigenetics: A Bidirectional Interplay that Drives Tumor Progression
por: Crispo, Fabiana, et al.
Publicado: (2019)

Editorial: Mechanisms of Epigenetics and Genetics in Leukemogenesis
por: Li, Yonghui, et al.
Publicado: (2022)

Editorial: Altered epigenetic modification mediated dysregulated transcriptional networks in drug resistance
por: Brunetti, Bryce, et al.
Publicado: (2023)

Editorial: Epigenetic Modifications in Mesothelioma
por: Cheng, Yuen Yee, et al.
Publicado: (2021)

Editorial: Epigenetics in prostate cancer
por: Baniahmad, Aria, et al.
Publicado: (2023)

Editorial: The role of transcription factors, stem cell markers and epigenetics contributing to chemoresistance in brain cancers
por: Castresana, Javier S., et al.
Publicado: (2023)

Editorial: The interconnection between epigenetic modifications and the tumor microenvironment
por: He, Siyuan, et al.
Publicado: (2023)

Editorial: Epigenetic Regulation and Tumor Immunotherapy
por: Sun, Hongyin, et al.
Publicado: (2022)

Editorial: Epigenetics and cellular plasticity in glioblastoma
por: Lo, Hui-Wen, et al.
Publicado: (2023)

Metabolo-epigenetic interplay provides targeted nutritional interventions in chronic diseases and ageing
por: Gómez de Cedrón, Marta, et al.
Publicado: (2023)

Editorial: Understanding the Interplay Between the Tumor Immune Microenvironment and Genetic Alterations in Thoracic Malignancies
por: Pasello, Giulia, et al.
Publicado: (2022)

The PARP Way to Epigenetic Changes
por: Ummarino, Simone, et al.
Publicado: (2021)

Editorial: Metabolism of anti-cancer drugs: Interplay involving pharmacology and pharmacokinetics
por: Bapiro, Tashinga E., et al.
Publicado: (2022)

Editorial: Host-pathogen interactions interplay and cancer: understanding mechanisms and beyond
por: Khan, Abdul Arif, et al.
Publicado: (2023)

Editorial: The Interplay Between Epigenetic Regulation and Other Cellular Processes
por: Tang, Kai, et al.
Publicado: (2021)

Editorial: Epigenetics and molecular genetics of rare tumors
por: Tognon, Mauro, et al.
Publicado: (2022)

Editorial: Epigenetic insights into diagnostic and therapeutic applications
por: Fratta, Elisabetta, et al.
Publicado: (2023)

Editorial: Interplay between RNA-binding proteins and non-coding RNAs in tumor therapeutic resistance
por: Dong, Peixin, et al.
Publicado: (2023)

Editorial: Transcription Factors Drivers of Malignancy, Progression and Poor Outcomes in Breast Cancer
por: Parisi, Eva, et al.
Publicado: (2022)

Homeostatic Imbalance and Colon Cancer: The Dynamic Epigenetic Interplay of Inflammation, Environmental Toxins, and Chemopreventive Plant Compounds
por: Sokolosky, Melissa L., et al.
Publicado: (2012)

Editorial: Epigenetic and metabolic regulation of primary and metastatic brain cancers
por: Gimple, Ryan C., et al.
Publicado: (2023)

Editorial: Genetic/epigenetic mechanisms and related clinical strategy in leukemia
por: Li, Yonghui, et al.
Publicado: (2023)

Editorial: Influences in the progression of renal cell carcinoma
por: Bacchiani, Mara, et al.
Publicado: (2022)

Reciprocal Interplay Between Fibrillar Collagens and Collagen-Binding Integrins: Implications in Cancer Progression and Metastasis
por: Bourgot, Isabelle, et al.
Publicado: (2020)

Editorial: Interplay Between RNA Processing Machinery and Epigenetic Regulation in Gene Expression
por: Kataoka, Naoyuki, et al.
Publicado: (2021)

An Overview of Epigenetic Methylation in Pancreatic Cancer Progression
por: Zhao, Yuhao, et al.
Publicado: (2022)

A spotlight on the interplay between Wnt/β-catenin signaling and circular RNAs in hepatocellular carcinoma progression
por: Mafi, Alireza, et al.
Publicado: (2023)

Editorial: DNA methylation: The aging clock
por: Ghinassi, Barbara, et al.
Publicado: (2023)

The interplay between autophagy and ROS in tumorigenesis
por: Kongara, Sameera, et al.
Publicado: (2012)

Understanding the Mechanisms by Which Epigenetic Modifiers Avert Therapy Resistance in Cancer
por: Quagliano, Anthony, et al.
Publicado: (2020)

Targeting Epigenetic Modifiers Can Reduce the Clonogenic Capacities of Sézary Cells
por: Chebly, Alain, et al.
Publicado: (2021)

Editorial: The role of iron in cancer progression
por: Hamaï, Ahmed, et al.
Publicado: (2022)

CXCL5: A coachman to drive cancer progression
por: Deng, Jie, et al.
Publicado: (2022)

Pre-Clinical Studies of Epigenetic Therapies Targeting Histone Modifiers in Lung Cancer
por: Huffman, Kenneth, et al.
Publicado: (2013)

Editorial: Ubiquitin-Modifying Enzymes as Drug Targets and Biomarkers in Cancer
por: Bell, Jessica L., et al.
Publicado: (2021)

Editorial: The Role of Platelets in Cancer Progression and Malignancy
por: Schlesinger, Martin, et al.
Publicado: (2021)

Editorial: Molecular and immune influences in the progression of gliomas
por: Malik, Karan, et al.
Publicado: (2023)

Editorial: 365 days of progress in radiation oncology
por: Kinsella, Timothy J.
Publicado: (2023)

Editorial: 365 days of progress in cancer genetics
por: Ratajska, Magdalena, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eg4hajcqvhg6598n1un6r4fcs9